C21 · Pharmaceuticals · Global
Registered interventional Alzheimer's disease drug trials
Global: 1,646 in as of 27 Sep 2026.
- 1,646 Latest · Global · as of 27 Sep 2026
- Irregular Release cadence
- 1 Record · 1 region · 2026
Verified 27 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Registered interventional Alzheimer's disease drug trials
Global, as of 27 Sep 2026
Every record
1 record · 1 region · 2026. Each period links to its record: the value, the quote it was read from, and the document.
| Period | Value | Source | Type |
|---|---|---|---|
| Global 1 record | |||
| as of 27 Sep 2026 | 1,646 | ClinicalTrials.gov · 27 Sep 2026 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: ClinicalTrials.gov. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (ClinicalTrials.gov); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Count of interventional drug or biologic studies in Alzheimer's disease on ClinicalTrials.gov, any start date.
- Measure
- One slice of Clinical trial registrations ( basis: clinicaltrials gov registry, counting rule: all registered, form: count, segment: alz ) . Total number of clinical trials registered with a clinical trials registry platform. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its quote before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| ClinicalTrials.gov study count: All interventional drug or biologic studies in Alzheimer's disease, any start date, as registered on 2026-09-27 | ClinicalTrials.gov | — | 1 |
Other slices of clinical trial registrations
- Clinical trial registrations 3
- New drug clinical trials 2 new drug
- Active Alzheimer's disease drug trials 1 clinicaltrials gov registry · currently active · alz
- Active GLP-1, incretin multi-agonist and amylin trials 1 clinicaltrials gov registry · currently active · glp1
- Active KRAS and RAS inhibitor trials 1 clinicaltrials gov registry · currently active · kras
- Active antibody-drug conjugate trials 1 clinicaltrials gov registry · currently active · adc
- Active autoimmune cell therapy and T-cell engager trials 1 clinicaltrials gov registry · currently active · autoimmune
- Active cardiometabolic RNA and next-generation lipid drug trials 1 clinicaltrials gov registry · currently active · rnacv
- Active gene editing trials 1 clinicaltrials gov registry · currently active · gene
- Active inflammatory bowel disease drug trials 1 clinicaltrials gov registry · currently active · ibd
- Active oncology bispecific antibody trials 1 clinicaltrials gov registry · currently active · bsab
- Active radioligand therapy trials 1 clinicaltrials gov registry · currently active · rlt
Frequently asked questions
What is the latest registered interventional Alzheimer's disease drug trials?
Global: 1,646 in as of 27 Sep 2026.
Where does this data come from?
From 1 document published by ClinicalTrials.gov. Every figure on this page links to its record, which quotes the sentence or table row the number was read from.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Registered interventional Alzheimer's disease drug trials [Data set]. Retrieved September 29, 2026, from https://statorigin.org/indicators/ctgov-alz-registered-trials
"Registered interventional Alzheimer's disease drug trials." StatOrigin, 2026, https://statorigin.org/indicators/ctgov-alz-registered-trials. Accessed 29 Sep. 2026.
StatOrigin. "Registered interventional Alzheimer's disease drug trials." Data set, 2026. Accessed September 29, 2026. https://statorigin.org/indicators/ctgov-alz-registered-trials.
@misc{statorigin_ctgov_alz_registered_trials_2026, title = {Registered interventional Alzheimer's disease drug trials}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/ctgov-alz-registered-trials}, note = {Data set. Accessed 2026-09-29} }